Economics and cost-effectiveness in evaluating the value of cardiovascular therapies. The value of cost-effectiveness analyses for reimbursement decisions: perspectives from Medicare.
Sheingold
S H
SH
Division of Program Analysis and Performance, Measurement Health Care Financing Administration, Baltimore, MD 21244-8150, USA.
D002318:Cardiovascular Diseases / Q000191:economics* / Q000628:therapy; D003362:Cost-Benefit Analysis; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D006278:Medicare / Q000191:economics*; D013673:Technology Assessment, Biomedical; D014481:United States